U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148323) titled 'HemoSphere Alta Study' on Aug. 13.
Brief Summary: A prospective, non-randomized single arm study using the HemoSphere Alta Advanced Monitoring Platform and associated devices in adult subjects. Data collected from enrolled study subjects will be used for continual device development purposes.
Study Start Date: Sept., 2025
Study Type: OBSERVATIONAL
Condition:
Hemodynamic Instability
Intervention:
DEVICE: HemoSphere Alta Monitor, Swan-Ganz IQ pulmonary arterial catheter, ForeSight IQ Large sensor, and Acumen IQ sensor
Subjects with planned monitoring with a pulmonary artery catheter in the operating room, will be monitored with...